BiotechTube
Home/Anbogen Therapeutics/Mark Horng, MD
MH

Mark Horng, MD

Chief Medical Officer

Anbogen Therapeutics

Therapeutic Areas

Oncology

Anbogen Therapeutics Pipeline

DrugIndicationPhase
ABT-301Advanced colorectal cancerPhase 1/2

Leadership Team at Anbogen Therapeutics

TH
Tsu-an Hsu, PhD
CEO / Co‑founder
JH
Joe Hsueh, MBA
President / COO
View full Anbogen Therapeutics profile